Mei Yi

3.1k total citations · 2 hit papers
49 papers, 2.1k citations indexed

About

Mei Yi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mei Yi has authored 49 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 19 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Mei Yi's work include Cancer-related gene regulation (10 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (8 papers). Mei Yi is often cited by papers focused on Cancer-related gene regulation (10 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (8 papers). Mei Yi collaborates with scholars based in China, United States and Saudi Arabia. Mei Yi's co-authors include Bo Xiang, Guiyuan Li, Zhaoyang Zeng, Yixin Tan, Xiaoling Li, Jing Cai, Wei Xiong, Yuanyuan Ban, Wei Xiong and Xiayu Li and has published in prestigious journals such as Nature Communications, Cellular and Molecular Life Sciences and Molecular Cancer.

In The Last Decade

Mei Yi

47 papers receiving 2.1k citations

Hit Papers

Pyroptosis: a new paradigm of cell death for fighting aga... 2021 2026 2022 2024 2021 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Yi China 21 1.4k 808 442 358 279 49 2.1k
Xuelai Luo China 29 1.6k 1.1× 768 1.0× 422 1.0× 394 1.1× 250 0.9× 62 2.2k
Guishuai Lv China 15 1.3k 0.9× 1.0k 1.3× 330 0.7× 305 0.9× 180 0.6× 18 2.0k
Kuo‐Tai Hua Taiwan 30 1.7k 1.2× 716 0.9× 492 1.1× 293 0.8× 179 0.6× 62 2.3k
Xiangjin Zheng China 21 1.2k 0.8× 609 0.8× 257 0.6× 235 0.7× 252 0.9× 27 1.7k
Wei-Chao Chang Taiwan 20 1.4k 0.9× 734 0.9× 648 1.5× 465 1.3× 529 1.9× 33 2.3k
Chia‐Lang Hsu Taiwan 25 1.1k 0.8× 480 0.6× 364 0.8× 387 1.1× 312 1.1× 118 1.8k
Leina Ma China 24 1.6k 1.1× 793 1.0× 536 1.2× 186 0.5× 164 0.6× 50 2.2k
Ce Li China 24 1.1k 0.8× 758 0.9× 624 1.4× 310 0.9× 201 0.7× 70 1.7k
Yong Gao China 26 1.5k 1.0× 750 0.9× 495 1.1× 211 0.6× 250 0.9× 97 2.0k

Countries citing papers authored by Mei Yi

Since Specialization
Citations

This map shows the geographic impact of Mei Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Yi more than expected).

Fields of papers citing papers by Mei Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Yi. The network helps show where Mei Yi may publish in the future.

Co-authorship network of co-authors of Mei Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Yi. A scholar is included among the top collaborators of Mei Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Yi. Mei Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Quanzhu, Pan Wu, Jing Cai, et al.. (2025). A moonlighting function of tumoral interleukin-1β precursor promotes metastasis via RACK1-mediated actin remodeling. Nature Communications. 16(1). 10148–10148.
2.
Lin, Xin, Chen Pan, Huai Liu, et al.. (2024). T cell exhaustion in human cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189162–189162. 12 indexed citations
3.
Ge, Junshang, Ying Liu, Pan Chen, et al.. (2024). FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 12(11). e010091–e010091. 3 indexed citations
4.
Lin, Xin, Pan Chen, Zhaoyang Zeng, et al.. (2024). Regulatory mechanisms of PD-1/PD-L1 in cancers. Molecular Cancer. 23(1). 108–108. 273 indexed citations breakdown →
5.
Yan, Mei, Chunmei Fan, Pan Chen, et al.. (2023). Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein. Cellular Oncology. 47(3). 833–850. 7 indexed citations
6.
Chen, Quanzhu, Qian Peng, Jing Cai, et al.. (2023). Super Enhancer Driven Hyaluronan Synthase 3 Promotes Malignant Progression of Nasopharyngeal Carcinoma. Journal of Cancer. 14(10). 1751–1762. 6 indexed citations
7.
Zhang, Yongchang, Li Wang, Min Li, et al.. (2022). FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma. Cell Death and Disease. 13(8). 711–711. 14 indexed citations
8.
Yang, Ruixue, Mei Yi, & Bo Xiang. (2022). Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer. Frontiers in Cell and Developmental Biology. 10. 875318–875318. 53 indexed citations
9.
Ban, Yuanyuan, Yixin Tan, Xiaoling Li, et al.. (2021). RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells via binding to AURKA mRNA. Journal of Cancer. 12(11). 3315–3324. 18 indexed citations
10.
Cai, Jing, Mei Yi, Yixin Tan, et al.. (2021). Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ. Journal of Experimental & Clinical Cancer Research. 40(1). 190–190. 152 indexed citations
11.
Tan, Yixin, Quanzhu Chen, Xiaoling Li, et al.. (2021). Pyroptosis: a new paradigm of cell death for fighting against cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 153–153. 345 indexed citations breakdown →
12.
Peng, Qian, Liyang Zhang, Junjun Li, et al.. (2020). FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p. Journal of Cancer. 11(9). 2485–2495. 30 indexed citations
13.
Yi, Mei, Wei Wang, Shengnan Chen, et al.. (2018). Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop. Molecular Biology Reports. 45(5). 1277–1287. 10 indexed citations
14.
Li, Junjun, Wei Wang, Shengnan Chen, et al.. (2018). FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma. Cancer Letters. 442. 1–14. 38 indexed citations
15.
Chen, Shengnan, Pan Zheng, Wei Wang, et al.. (2017). Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN‐induced hepatocellular carcinoma. Journal of Cellular Physiology. 233(6). 5002–5013. 27 indexed citations
16.
Wang, Wei, Mei Yi, Renya Zhang, et al.. (2017). Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma. Molecular and Cellular Biochemistry. 438(1-2). 47–57. 35 indexed citations
17.
Yi, Mei, Jianbo Yang, Wenjuan Li, et al.. (2017). The NOR1/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor. Journal of Cancer. 8(4). 626–635. 19 indexed citations
18.
Li, Wenjuan, Xiaoling Li, Wei Wang, et al.. (2013). Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro. The International Journal of Biochemistry & Cell Biology. 45(9). 2016–2026. 21 indexed citations
19.
Zeng, Zhaoyang, Hongbin Huang, Bo Xiang, et al.. (2011). Nasopharyngeal carcinoma: Advances in genomics and molecular genetics. Science China Life Sciences. 54(10). 966–975. 53 indexed citations
20.
Yi, Mei. (2003). Relationship between the gene polymorphism of MTHFR and the cerebral thrombosis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026